Vaccine Quo Vadis?

20 July 2010

Alan Bernstein, O.C., Ph.D.Executive Director,Global HIV Vaccine Enterprise

v

Transforming the Global HIV Vaccine Research Effort

New minds and new ideas

Unified clinical trials agenda

Global data infrastructure and sharing

Broaden and increase funding

Global HIV Vaccine Enterprise: Engaging the Scientific Community

The 2010 Plan: The Framework For A New Era of HIV Vaccine Research

• Developed by the Enterprise Council involving the Enterprise Science Committee and five Working Groups

• Input of more than 400 researchers, policy-makers, funders and advocates worldwide

• An agreement of partners to align their independent strategies to maximize opportunities for cooperation in HIV vaccine research

v

AIDS Vaccine Asian Network

Global HIV Vaccine Enterprise: Promoting Scientific Collaboration